We are live on ! Find out more
WVE icon

Wave Life Sciences
WVE

79 hedge funds and large institutions have $949M invested in Wave Life Sciences in 2018 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 32 increasing their positions, 21 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

78% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 9

52% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 21

22% more capital invested

Capital invested by funds: $780M → $949M (+$169M)

8% more funds holding

Funds holding: 73 → 79 (+6)

4.57% more ownership

Funds ownership: 79.98% → 84.54% (+4.6%)

14% less funds holding in top 10

Funds holding in top 10: 7 → 6 (-1)

Holders
79
Holders Change
+6
Holders Change %
+8.22%
% of All Funds
1.81%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.14%
New
16
Increased
32
Reduced
21
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BC
Boxer Capital
California
+$33.6M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$27.3M
3
EC
EcoR1 Capital
California
+$22M
4
BM
Bridger Management
New York
+$7.63M
5
SIM
Spark Investment Management
New York
+$3.05M

Top Sellers

Rank Fund Capital Flow
1
GPP
Great Point Partners
Connecticut
-$11.6M
2
PA
Perceptive Advisors
New York
-$8.41M
3
CAM
Cormorant Asset Management
Massachusetts
-$7.09M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$5.53M
5
FCMI
Foresite Capital Management III
California
-$3.67M
Name Holding Trade Value Shares
Change 		Change in
Stake
FCMI
26
Foresite Capital Management III
California
$3.01M -$3.67M -87,347 -54%
DCM
27
Driehaus Capital Management
Illinois
$2.78M +$2.91M +69,299 New
Charles Schwab
28
Charles Schwab
California
$2.76M -$235K -5,593 -8%
Deutsche Bank
29
Deutsche Bank
Germany
$2.59M +$1.62M +38,472 +147%
D.E. Shaw & Co
30
D.E. Shaw & Co
New York
$2.29M +$2.13M +50,610 +786%
EI
31
EAM Investors
California
$2.19M +$2.29M +54,522 New
B
32
Bailard
California
$2.11M -$1.11M -26,300 -33%
PPA
33
Parametric Portfolio Associates
Washington
$1.95M +$1.2M +28,581 +143%
EU
34
Emory University
Georgia
$1.92M -$636K -15,127 -24%
PP
35
PDT Partners
New York
$1.8M +$1.89M +44,900 New
DCM
36
DAFNA Capital Management
California
$1.78M +$1.87M +44,400 New
Point72 Asset Management
37
Point72 Asset Management
Connecticut
$1.7M -$2.43M -57,700 -58%
SSA
38
Schonfeld Strategic Advisors
New York
$1.61M -$1.86M -44,193 -52%
MC
39
Matisse Capital
Oregon
$1.45M -$450K -10,700 -23%
PIM
40
Platinum Investment Management
Australia
$1.29M +$1.35M +32,200 New
TCIM
41
TIAA CREF Investment Management
New York
$1.2M +$10.6K +251 +0.8%
Morgan Stanley
42
Morgan Stanley
New York
$1.08M +$49.5K +1,178 +5%
Ameriprise
43
Ameriprise
Minnesota
$943K +$989K +23,516 New
ARTA
44
A.R.T. Advisors
New York
$937K -$90.6K -2,155 -8%
TA
45
Teachers Advisors
New York
$864K – – –
GCP
46
GSA Capital Partners
United Kingdom
$806K +$387K +9,200 +84%
WC
47
Wexford Capital
Florida
$802K – – –
Swiss National Bank
48
Swiss National Bank
Switzerland
$778K +$42K +1,000 +5%
California State Teachers Retirement System (CalSTRS)
49
California State Teachers Retirement System (CalSTRS)
California
$723K -$29.3K -696 -4%
DZ Bank
50
DZ Bank
Germany
$722K +$757K +18,017 New
1
2
3 4

WVE Hedge Fund Activity: Q1 2018 in Review

79 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q1 2018, worth a combined $949M — up 22% from $780M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new WVE positions and 9 closed out — a net gain of 7 holders — while 32 added to existing stakes and 21 trimmed.

The largest buyer was Boxer Capital, adding an estimated $33.6M. The largest seller was Great Point Partners, exiting entirely with an estimated $11.6M sold.

  • 79 institutional investors held Wave Life Sciences (WVE) as of Q1 2018, up from 73 in Q4 2017.
  • Funds reported $949M of Wave Life Sciences stock for Q1 2018, up 22% quarter-over-quarter.
  • 16 funds opened new Wave Life Sciences positions in Q1 2018 and 9 closed out, a net change of +7 holders.
  • The largest Wave Life Sciences buyer in Q1 2018 was Boxer Capital, an estimated $33.6M added.
  • The largest Wave Life Sciences seller in Q1 2018 was Great Point Partners, an estimated $11.6M sold.

Based on aggregated 13F filings for Q1 2018.